Sign in

NCT05880446Completed

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)

PROstate CAncer Radiotherapy: Its Real Impact on Bowel Symptoms & Quality of Life Today, Measured by the EORTC QLQ C30 & Specific PRT20 Module.

Source: ClinicalTrials.gov · Last updated 13 May 2024

Brief summary (registry, in English)

This is a prospective pilot study to evaluate the mean increase of bowel symptoms after pelvic radiotherapy (RT) in prostate cancer (PCa) patient using the validated \& newly translated EORTC-QLQ PRT20 module.

Status (registry)
Completed
Study type
Interventional
Enrollment
41 (actual)
First submitted
10 May 2023
Start date
6 Oct 2023
Primary completion date
29 Mar 2024
Lead sponsor
Jules Bordet Institute
NCT number
NCT05880446

What you commit to

  • Study type: Interventional
  • Participants enrolled: 41
  • From 6 Oct 2023 to the primary completion date, 29 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous RT to the pelvis

Other illness

  • Diagnosed Inflammatory Bowel Disease (IBD), celiac disease
  • Obvious cognitive impairment,

Other

  • Severe GI symptoms before the beginning of RT (Grade \> 2 according to CTCAE grading system)
  • Inability to understand French/English and no contact person able to accompany and translate.

Who the study is looking for

  • Men with PCa which are candidate for pelvic radiotherapy (RT) with or without previous surgery, with or without concomitant hormonotherapy (HT), Performance status (PS) 0-2 (all patient able to undergo RT treatment), of all age, elderly included.

Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Institut Jules Bordet
Coordinator of this site? Confirm its status
AnderlechtBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.